secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2023-04-03T23:59:59+00:00
Accession:  0001140361-23-015888
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE reports record FY2022 revenue of $16.7M, restates prior quarterly financials
--------------------------------------------------------------------------------

- FY2022 revenue $16.7M (+29% YoY); Q4 revenue $5.5M (+32% vs Q3 2022).
- GAAP operating loss improved to $9.0M in FY2022 from $14.1M in 2021; Q4 op loss $1.5M.
- Restated Q1, Q2, Q3 2022 financials due to material errors in accounting for shares, asset sales, vendor invoices, interest, inventory.
- Q1 2023 guidance: revenue growth 14-20% vs Q1 2022; supply constraint alleviated.
- New executives added (EVP Sales, VP Commercial Ops, VP Ops); stock now trades on OTCQB.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123015888/0001140361-23-015888-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123015888/brhc10050787_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-015888

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer